EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank93
3Y CAGR+26.4%
5Y CAGR+31.7%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
+26.4%/yr
vs +26.0%/yr prior
5Y CAGR
+31.7%/yr
Recent deceleration
Acceleration
+0.4pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $364.00M | -13.0% |
| 2024 | $418.46M | +17.8% |
| 2023 | $355.18M | +96.9% |
| 2022 | $180.36M | -31.5% |
| 2021 | $263.37M | +187.2% |
| 2020 | $91.72M | +25.7% |
| 2019 | $72.97M | +1.8% |
| 2018 | $71.67M | +283.7% |
| 2017 | $18.68M | -40.9% |
| 2016 | $31.62M | - |